Physician profile
Royce E Hood
NPI 1376507707
$697.98
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $36.36 · 2021: $163 · 2022: $127 · 2023: $35.54 · 2024: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $136.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $307.84 | 2021-2024 | Insignia |
| Amgen INC. | $140.76 | 2019 | |
| Zimmer Biomet Holdings, INC. | $41.05 | 2019-2022 | |
| Smith+Nephew, INC. | $36.07 | 2021-2022 | |
| Ermi LLC | $33.29 | 2020-2021 | |
| Ferring Pharmaceuticals INC. | $32.82 | 2019-2023 | Rebyota |
| Pacira Therapeutics, INC. | $28.37 | 2019 | |
| Orthogenrx INC. | $24.96 | 2019 | |
| Bioventus LLC | $23.35 | 2020 | |
| Si-Bone, INC. | $14.91 | 2019 | |
| Kerecis Limited | $14.56 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Royce Hood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.